Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Journal of Computer-Aided Molecular Design|December 16, 2011
In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin)Pradeep K Naik, Manu Lopus, Ritu Aneja, et al.Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Copper(I) mediated facile synthesis of potent tubulin polymerization inhibitor, 9-amino-α-noscapine from natural α-noscapineNaresh K Manchukonda, Balasubramanian Sridhar, Pradeep K Naik, et al.Cancer Research|April 19, 2007
p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cellsRitu Aneja, Amr M Ghaleb, Jun Zhou, et al.Cancer Research|January 7, 2006
Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinaseJun Zhou, Min Liu, Ritu Aneja, et al.Molecular Pharmacology|March 7, 2006
Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphomaRitu Aneja, Surya N Vangapandu, Manu Lopus, et al.Blood|November 12, 2005
Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011Ritu Aneja, Jun Zhou, Surya N Vangapandu, et al.Plos One|August 1, 2012
Noscapine induced apoptosis via downregulation of survivin in human neuroblastoma cells having wild type or null p53Shiwang Li, Jing He, Shuai Li, et al.Molecular Pharmacology|March 20, 2003
Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferationJun Zhou, Kamlesh Gupta, Shefali Aggarwal, et al.The Journal of Biological Chemistry|August 17, 2002
Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapineJun Zhou, Kamlesh Gupta, Joyce Yao, et al.The Journal of Biological Chemistry|April 25, 2007
PO(2)-dependent differential regulation of multidrug resistance 1 gene expression by the c-Jun NH2-terminal kinase pathwayMin Liu, Dengwen Li, Ritu Aneja, et al.Pageof 5